<DOC>
	<DOC>NCT00566514</DOC>
	<brief_summary>The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.</brief_summary>
	<brief_title>The Role of Ribose in Patients Diagnosed With Fibromyalgia</brief_title>
	<detailed_description>Two hundred to three hundred subjects (equally distribued between placebo and D-ribose) between 18-78 years of age will comprise this study. The final numbers enrolled will depend upon obtaining approximately 100 subjects that can display a high degree of compliance to TID dosing with approximately equal balance between the active and placebo arms.</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>previous diagnosis of fibromomyalgia by a MD Has been diagnosed with fibromyalgia and are over 18 years of age Does live in the United States does NOT have severe medication/chemical/supplement sensitivities does NOT have insulin dependent diabetes or other severe illnesses (cancer, hepatitis, congestive heart failure) does NOT have rheumatoid arthritis or gout previous use of ribose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>fibromyalgia</keyword>
	<keyword>ribose</keyword>
	<keyword>d-ribose</keyword>
	<keyword>dextrose</keyword>
</DOC>